These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
(Mark one)
|
|
[x]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
77-0228183
|
|
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
|
Identification Number)
|
|
|
|
|
|
|
|
2700 N. First St., San Jose, CA
|
|
95134
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large Accelerated Filer
|
[X]
|
Accelerated filer [ ]
|
Non-accelerated filer [ ]
|
Smaller reporting company [ ]
|
|
|
|
(Do not check if a smaller
reporting company)
|
Emerging growth company [ ]
|
|
|
Page
|
|
|
|
Item 1.
|
||
|
||
|
||
|
||
|
||
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
|
|
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 6.
|
||
|
|
As of
|
||||||
|
December 30,
2017 |
|
September 30,
2017 |
||||
|
(Unaudited)
|
||||||
|
(In thousands)
|
||||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
404,914
|
|
|
$
|
406,661
|
|
Accounts receivable, net of allowances of $13,727 and $14,334 as of December 30, 2017 and September 30, 2017, respectively
|
1,121,800
|
|
|
1,110,334
|
|
||
Inventories
|
1,079,638
|
|
|
1,051,669
|
|
||
Prepaid expenses and other current assets
|
46,345
|
|
|
47,586
|
|
||
Total current assets
|
2,652,697
|
|
|
2,616,250
|
|
||
Property, plant and equipment, net
|
635,000
|
|
|
640,275
|
|
||
Deferred tax assets
|
356,660
|
|
|
476,554
|
|
||
Other
|
114,223
|
|
|
114,284
|
|
||
Total assets
|
$
|
3,758,580
|
|
|
$
|
3,847,363
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
1,260,432
|
|
|
$
|
1,280,106
|
|
Accrued liabilities
|
121,001
|
|
|
116,582
|
|
||
Accrued payroll and related benefits
|
111,806
|
|
|
130,939
|
|
||
Short-term debt, including current portion of long-term debt
|
169,416
|
|
|
88,416
|
|
||
Total current liabilities
|
1,662,655
|
|
|
1,616,043
|
|
||
Long-term liabilities:
|
|
|
|
||||
Long-term debt
|
392,195
|
|
|
391,447
|
|
||
Other
|
202,142
|
|
|
192,189
|
|
||
Total long-term liabilities
|
594,337
|
|
|
583,636
|
|
||
Contingencies (Note 5)
|
|
|
|
||||
Stockholders' equity
|
1,501,588
|
|
|
1,647,684
|
|
||
Total liabilities and stockholders' equity
|
$
|
3,758,580
|
|
|
$
|
3,847,363
|
|
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(Unaudited)
|
||||||
|
(In thousands, except per share data)
|
||||||
Net sales
|
$
|
1,744,800
|
|
|
$
|
1,719,977
|
|
Cost of sales
|
1,635,334
|
|
|
1,587,815
|
|
||
Gross profit
|
109,466
|
|
|
132,162
|
|
||
|
|
|
|
||||
Operating expenses:
|
|
|
|
||||
Selling, general and administrative
|
63,603
|
|
|
65,140
|
|
||
Research and development
|
7,615
|
|
|
8,171
|
|
||
Restructuring costs
|
23,542
|
|
|
728
|
|
||
Other
|
918
|
|
|
(533
|
)
|
||
Total operating expenses
|
95,678
|
|
|
73,506
|
|
||
|
|
|
|
||||
Operating income
|
13,788
|
|
|
58,656
|
|
||
|
|
|
|
||||
Interest income
|
285
|
|
|
201
|
|
||
Interest expense
|
(6,214
|
)
|
|
(5,267
|
)
|
||
Other income, net
|
3,230
|
|
|
1,257
|
|
||
Interest and other, net
|
(2,699
|
)
|
|
(3,809
|
)
|
||
|
|
|
|
||||
Income before income taxes
|
11,089
|
|
|
54,847
|
|
||
Provision for income taxes
|
165,999
|
|
|
9,983
|
|
||
Net income (loss)
|
$
|
(154,910
|
)
|
|
$
|
44,864
|
|
|
|
|
|
||||
Net income (loss) per share:
|
|
|
|
||||
Basic
|
$
|
(2.16
|
)
|
|
$
|
0.61
|
|
Diluted
|
$
|
(2.16
|
)
|
|
$
|
0.58
|
|
|
|
|
|
||||
Weighted average shares used in computing per share amounts:
|
|
|
|
||||
Basic
|
71,605
|
|
|
73,554
|
|
||
Diluted
|
71,605
|
|
|
77,175
|
|
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(Unaudited)
|
||||||
|
(In thousands)
|
||||||
Net income (loss)
|
$
|
(154,910
|
)
|
|
$
|
44,864
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
||||
Change in foreign currency translation adjustments
|
(354
|
)
|
|
(2,156
|
)
|
||
Derivative financial instruments:
|
|
|
|
||||
Change in net unrealized amount
|
(1,407
|
)
|
|
(2,169
|
)
|
||
Amount reclassified into net income
|
1,525
|
|
|
1,926
|
|
||
Defined benefit plans:
|
|
|
|
||||
Changes in unrecognized net actuarial losses and unrecognized transition costs
|
(260
|
)
|
|
1,060
|
|
||
Amortization of actuarial losses and transition costs
|
321
|
|
|
599
|
|
||
Total other comprehensive loss
|
(175
|
)
|
|
(740
|
)
|
||
Comprehensive income (loss)
|
$
|
(155,085
|
)
|
|
$
|
44,124
|
|
|
|
|
|
|
|||||||
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(Unaudited)
|
||||||
|
(In thousands)
|
||||||
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
|
|
|
|
||||
Net income (loss)
|
$
|
(154,910
|
)
|
|
$
|
44,864
|
|
Adjustments to reconcile net income (loss) to cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
29,623
|
|
|
28,972
|
|
||
Stock-based compensation expense
|
8,642
|
|
|
11,977
|
|
||
Deferred income taxes
|
163,173
|
|
|
1,477
|
|
||
Other, net
|
(130
|
)
|
|
644
|
|
||
Changes in operating assets and liabilities, net of acquisitions:
|
|
|
|
||||
Accounts receivable
|
(11,156
|
)
|
|
(22,849
|
)
|
||
Inventories
|
(28,293
|
)
|
|
(19,306
|
)
|
||
Prepaid expenses and other assets
|
4,103
|
|
|
1,614
|
|
||
Accounts payable
|
6,304
|
|
|
39,391
|
|
||
Accrued liabilities
|
(8,916
|
)
|
|
(32,857
|
)
|
||
Cash provided by operating activities
|
8,440
|
|
|
53,927
|
|
||
|
|
|
|
||||
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES:
|
|
|
|
||||
Purchases of property, plant and equipment
|
(48,533
|
)
|
|
(21,667
|
)
|
||
Proceeds from sales of property, plant and equipment
|
142
|
|
|
3,582
|
|
||
Cash used in investing activities
|
(48,391
|
)
|
|
(18,085
|
)
|
||
|
|
|
|
||||
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES:
|
|
|
|
||||
Proceeds from revolving credit facility borrowings
|
899,000
|
|
|
208,400
|
|
||
Repayments of revolving credit facility borrowings
|
(818,000
|
)
|
|
(233,400
|
)
|
||
Net proceeds from stock issuances
|
2,526
|
|
|
10,643
|
|
||
Repurchases of common stock
|
(45,485
|
)
|
|
(13,623
|
)
|
||
Holdback payment for a prior business combination
|
—
|
|
|
(2,262
|
)
|
||
Cash provided by (used in) financing activities
|
38,041
|
|
|
(30,242
|
)
|
||
|
|
|
|
||||
Effect of exchange rate changes
|
163
|
|
|
1,352
|
|
||
Increase (decrease) in cash and cash equivalents
|
(1,747
|
)
|
|
6,952
|
|
||
Cash and cash equivalents at beginning of period
|
406,661
|
|
|
398,288
|
|
||
Cash and cash equivalents at end of period
|
$
|
404,914
|
|
|
$
|
405,240
|
|
|
|
|
|
||||
Cash paid during the period for:
|
|
|
|
||||
Interest, net of capitalized interest
|
$
|
12,352
|
|
|
$
|
8,543
|
|
Income taxes, net of refunds
|
$
|
7,275
|
|
|
$
|
5,593
|
|
Unpaid purchases of property, plant and equipment at the end of period
|
$
|
24,004
|
|
|
$
|
34,015
|
|
|
As of
|
||||||
|
December 30,
2017 |
|
September 30,
2017 |
||||
|
(In thousands)
|
||||||
Raw materials
|
$
|
851,665
|
|
|
$
|
834,694
|
|
Work-in-process
|
101,777
|
|
|
106,914
|
|
||
Finished goods
|
126,196
|
|
|
110,061
|
|
||
Total
|
$
|
1,079,638
|
|
|
$
|
1,051,669
|
|
|
As of
|
||||||
|
December 30, 2017
|
|
September 30, 2017
|
||||
Derivatives Designated as Accounting Hedges:
|
|
|
|
||||
Notional amount (in thousands)
|
$
|
84,867
|
|
|
$
|
105,523
|
|
Number of contracts
|
51
|
|
|
58
|
|
||
Derivatives Not Designated as Accounting Hedges:
|
|
|
|
||||
Notional amount (in thousands)
|
$
|
283,598
|
|
|
$
|
302,944
|
|
Number of contracts
|
39
|
|
|
46
|
|
|
As of
|
||||||
|
December 30,
2017 |
|
September 30,
2017 |
||||
|
(In thousands)
|
||||||
Senior secured notes due 2019
|
375,000
|
|
|
375,000
|
|
||
Non-interest bearing promissory notes
|
20,611
|
|
|
19,863
|
|
||
Total long-term debt
|
395,611
|
|
|
394,863
|
|
||
Less: Current portion of non-interest bearing promissory notes
|
3,416
|
|
|
3,416
|
|
||
Long-term debt
|
$
|
392,195
|
|
|
$
|
391,447
|
|
•
|
accounts receivable and all supporting obligations, chattel paper, documents and instruments in respect thereof or relating thereto;
|
•
|
deposit accounts;
|
•
|
inventory;
|
•
|
equity interests of the Company and the guarantors in their direct subsidiaries, subject to limited exceptions; intercompany debt at any time owing to the Company and the guarantors from a Canadian subsidiary;
|
•
|
cash;
|
•
|
accessions to, substitutions for, and all replacements, products, and cash and non-cash proceeds of the foregoing; and
|
•
|
all books and records pertaining to the foregoing.
|
|
Estimated Costs to Implement
|
|
Restructuring Expense for the three months ended December 30, 2017
|
||||
|
(In thousands)
|
||||||
Severance costs (approximately 2,900 employees)
|
$
|
27,700
|
|
|
$
|
23,301
|
|
Other exit costs (will be recognized as incurred)
|
7,300
|
|
|
—
|
|
||
Total - Q1 FY18 plan
|
$
|
35,000
|
|
|
$
|
23,301
|
|
Costs incurred for other plans
|
—
|
|
|
241
|
|
||
Total - all plans
|
$
|
35,000
|
|
|
$
|
23,542
|
|
|
As of
|
||||||
|
December 30,
2017 |
|
September 30,
2017 |
||||
|
(In thousands)
|
||||||
Foreign currency translation adjustments
|
$
|
90,598
|
|
|
$
|
90,952
|
|
Unrealized holding losses on derivative financial instruments
|
(94
|
)
|
|
(212
|
)
|
||
Unrecognized net actuarial losses and transition costs for benefit plans
|
(13,885
|
)
|
|
(13,946
|
)
|
||
Total
|
$
|
76,619
|
|
|
$
|
76,794
|
|
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(In thousands)
|
||||||
Gross sales:
|
|
|
|
||||
IMS
|
$
|
1,428,847
|
|
|
$
|
1,414,270
|
|
CPS
|
356,729
|
|
|
351,074
|
|
||
Intersegment revenue
|
(40,776
|
)
|
|
(45,367
|
)
|
||
Net sales
|
$
|
1,744,800
|
|
|
$
|
1,719,977
|
|
|
|
|
|
||||
Gross profit:
|
|
|
|
||||
IMS
|
$
|
82,617
|
|
|
$
|
102,637
|
|
CPS
|
29,866
|
|
|
33,289
|
|
||
Total
|
112,483
|
|
|
135,926
|
|
||
Unallocated items (1)
|
(3,017
|
)
|
|
(3,764
|
)
|
||
Total
|
$
|
109,466
|
|
|
$
|
132,162
|
|
(1)
|
For purposes of evaluating segment performance, management excludes certain items from its measure of gross profit. These items consist of stock-based compensation expense, amortization of intangible assets, charges or credits resulting from distressed customers and acquisition-related item.
|
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(In thousands)
|
||||||
Net sales
|
|
|
|
||||
United States
|
$
|
314,808
|
|
|
$
|
299,876
|
|
Mexico
|
489,234
|
|
|
474,160
|
|
||
China
|
315,092
|
|
|
321,739
|
|
||
Malaysia
|
185,712
|
|
|
211,191
|
|
||
Other international
|
439,954
|
|
|
413,011
|
|
||
Total
|
$
|
1,744,800
|
|
|
$
|
1,719,977
|
|
Percentage of net sales represented by ten largest customers
|
54
|
%
|
|
52
|
%
|
Number of customers representing 10% or more of net sales
|
2
|
|
|
2
|
|
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(In thousands, except per share data)
|
||||||
Numerator:
|
|
|
|
||||
Net income (loss)
|
$
|
(154,910
|
)
|
|
$
|
44,864
|
|
|
|
|
|
||||
Denominator:
|
|
|
|
||||
Weighted average common shares outstanding
|
71,605
|
|
|
73,554
|
|
||
Effect of dilutive stock options and restricted stock units
|
—
|
|
|
3,621
|
|
||
Denominator for diluted earnings per share
|
71,605
|
|
|
77,175
|
|
||
|
|
|
|
||||
Net income (loss) per share:
|
|
|
|
||||
Basic
|
$
|
(2.16
|
)
|
|
$
|
0.61
|
|
Diluted
|
$
|
(2.16
|
)
|
|
$
|
0.58
|
|
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(In thousands)
|
||||||
Stock options
|
$
|
1,177
|
|
|
$
|
550
|
|
Restricted stock units, including performance based awards
|
7,465
|
|
|
11,427
|
|
||
Total
|
$
|
8,642
|
|
|
$
|
11,977
|
|
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(In thousands)
|
||||||
Cost of sales
|
$
|
2,448
|
|
|
$
|
2,864
|
|
Selling, general and administrative
|
6,164
|
|
|
8,840
|
|
||
Research and development
|
30
|
|
|
273
|
|
||
Total
|
$
|
8,642
|
|
|
$
|
11,977
|
|
|
Number of
Shares
|
|
Weighted-
Average
Exercise Price
($)
|
|
Weighted-
Average
Remaining
Contractual
Term
(Years)
|
|
Aggregate
Intrinsic
Value of
In-The-Money
Options
($)
|
|||
|
(In thousands)
|
|
|
|
|
|
(In thousands)
|
|||
Outstanding as of September 30, 2017
|
3,568
|
|
|
11.83
|
|
|
3.82
|
|
90,327
|
|
Granted
|
200
|
|
|
38.45
|
|
|
|
|
|
|
Exercised/Cancelled/Forfeited/Expired
|
(234
|
)
|
|
12.43
|
|
|
|
|
|
|
Outstanding as of December 30, 2017
|
3,534
|
|
|
13.30
|
|
|
4.06
|
|
62,548
|
|
Vested and expected to vest as of December 30, 2017
|
3,530
|
|
|
13.29
|
|
|
4.06
|
|
62,519
|
|
Exercisable as of December 30, 2017
|
3,314
|
|
|
11.93
|
|
|
3.74
|
|
62,097
|
|
|
Number of
Shares
|
|
Weighted-
Average Grant Date
Fair Value
($)
|
|
Weighted-
Average
Remaining
Contractual
Term
(Years)
|
|
Aggregate
Intrinsic
Value
($)
|
|||
|
(In thousands)
|
|
|
|
|
|
(In thousands)
|
|||
Outstanding as of September 30, 2017
|
3,359
|
|
|
27.56
|
|
|
1.51
|
|
124,800
|
|
Granted
|
694
|
|
|
35.86
|
|
|
|
|
|
|
Vested/Forfeited/Cancelled
|
(699
|
)
|
|
25.76
|
|
|
|
|
|
|
Outstanding as of December 30, 2017
|
3,354
|
|
|
29.65
|
|
|
1.69
|
|
102,465
|
|
Expected to vest as of December 30, 2017
|
2,521
|
|
|
28.83
|
|
|
1.65
|
|
77,002
|
|
1.
|
Integrated Manufacturing Solutions (IMS). Our IMS segment consists of printed circuit board assembly and test, final system assembly and test and direct-order-fulfillment.
|
2.
|
Components, Products and Services (CPS). Components include interconnect systems (printed circuit board fabrication, backplane and cable assemblies and plastic injection molding) and mechanical systems (enclosures and precision machining). Products include memory, RF, optical and microelectronics solutions from our Viking Technology division, defense and aerospace products from SCI Technology, data storage solutions from our Newisys division and cloud-based manufacturing execution solutions from our 42Q division. Services include design, engineering, logistics and repair services.
|
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(In thousands)
|
||||||
Net sales
|
$
|
1,744,800
|
|
|
$
|
1,719,977
|
|
Gross profit
|
$
|
109,466
|
|
|
$
|
132,162
|
|
Operating income
|
$
|
13,788
|
|
|
$
|
58,656
|
|
Net income (loss) (1)
|
$
|
(154,910
|
)
|
|
$
|
44,864
|
|
|
Three Months Ended
|
||||||||||||
|
December 30, 2017
|
|
December 31, 2016
|
|
Increase/(Decrease)
|
||||||||
Industrial, Medical and Defense
|
$
|
795,642
|
|
|
$
|
777,497
|
|
|
$
|
18,145
|
|
2.3
|
%
|
Communications Networks
|
678,846
|
|
|
642,589
|
|
|
36,257
|
|
5.6
|
%
|
|||
Embedded Computing and Storage
|
270,312
|
|
|
299,891
|
|
|
(29,579
|
)
|
(9.9
|
)%
|
|||
Total
|
$
|
1,744,800
|
|
|
$
|
1,719,977
|
|
|
$
|
24,823
|
|
1.4
|
%
|
•
|
Changes in customer demand and sales volumes for our vertically integrated system components and subassemblies;
|
•
|
Changes in the overall volume of our business, which affect the level of capacity utilization;
|
•
|
Changes in the mix of high and low margin products demanded by our customers;
|
•
|
Parts shortages and extended parts lead times caused by high demand or natural disasters, and related operational disruption and inefficiencies;
|
•
|
Greater competition in the EMS industry and pricing pressures from OEMs due to greater focus on cost reduction;
|
•
|
Provisions for excess and obsolete inventory, including provisions associated with distressed customers;
|
•
|
Levels of operational efficiency and production yields;
|
•
|
Wage inflation and rising materials costs;
|
•
|
Our ability to transition the location of and ramp manufacturing and assembly operations when requested by a customer in a timely and cost-effective manner.
|
|
Estimated Costs to Implement
|
|
Restructuring Expense for the three months ended December 30, 2017
|
||||
|
(In thousands)
|
||||||
Severance costs (approximately 2,900 employees)
|
$
|
27,700
|
|
|
$
|
23,301
|
|
Other exit costs (will be recognized as incurred)
|
7,300
|
|
|
—
|
|
||
Total - Q1 FY18 plan
|
$
|
35,000
|
|
|
$
|
23,301
|
|
Costs incurred for other plans
|
—
|
|
|
241
|
|
||
Total - all plans
|
$
|
35,000
|
|
|
$
|
23,542
|
|
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(In thousands)
|
||||||
Foreign exchange gains
|
$
|
1,528
|
|
|
$
|
1,226
|
|
Other, net
|
1,702
|
|
|
31
|
|
||
Total
|
$
|
3,230
|
|
|
$
|
1,257
|
|
|
Three Months Ended
|
||||||
|
December 30,
2017 |
|
December 31,
2016 |
||||
|
(In thousands)
|
||||||
Net cash provided by (used in):
|
|
|
|
||||
Operating activities
|
$
|
8,440
|
|
|
$
|
53,927
|
|
Investing activities
|
(48,391
|
)
|
|
(18,085
|
)
|
||
Financing activities
|
38,041
|
|
|
(30,242
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
163
|
|
|
1,352
|
|
||
Increase (decrease) in cash and cash equivalents
|
$
|
(1,747
|
)
|
|
$
|
6,952
|
|
|
As of
|
||
|
December 30,
2017 |
|
September 30,
2017 |
Days sales outstanding (1)
|
58
|
|
55
|
Inventory turns (2)
|
6.1
|
|
6.2
|
Days inventory on hand (3)
|
59
|
|
59
|
Accounts payable days (4)
|
71
|
|
71
|
Cash cycle days (5)
|
46
|
|
43
|
(1)
|
Days sales outstanding (a measure of how quickly we collect our accounts receivable), or "DSO", is calculated as the ratio of average accounts receivable, net, to average daily net sales for the quarter.
|
(2)
|
Inventory turns (annualized) are calculated as the ratio of four times our cost of sales for the quarter to average inventory.
|
(3)
|
Days inventory on hand is calculated as the ratio of average inventory for the quarter to average daily cost of sales for the quarter.
|
(4)
|
Accounts payable days (a measure of how quickly we pay our suppliers), or "DPO", is calculated as the ratio of 365 days divided by accounts payable turns, in which accounts payable turns is calculated as the ratio of four times our cost of sales for the quarter to average accounts payable.
|
(5)
|
Cash cycle days is calculated as days inventory on hand plus days sales outstanding minus accounts payable days.
|
•
|
accounts receivable and all supporting obligations, chattel paper, documents and instruments in respect thereof or relating thereto;
|
•
|
deposit accounts;
|
•
|
inventory;
|
•
|
equity interests of Sanmina and the guarantors in their direct subsidiaries, subject to limited exceptions; intercompany debt at any time owing to Sanmina and the guarantors from a Canadian subsidiary;
|
•
|
cash;
|
•
|
accessions to, substitutions for, and all replacements, products, and cash and non-cash proceeds of the foregoing; and
|
•
|
all books and records pertaining to the foregoing.
|
•
|
intense competition among our customers and their competitors, leading to reductions in prices for their products and pricing pressures on us;
|
•
|
failure of our customers' products to gain widespread commercial acceptance which could decrease the volume of orders customers place with us;
|
•
|
changes in regulatory requirements affecting the products we build for our customers, leading to product obsolescence and potentially causing us to lose business; and
|
•
|
recessionary periods in our customers' markets, including the currently depressed conditions in the oil and gas industry, which decrease orders from affected customers.
|
•
|
our ability to replace declining sales from end-of-life programs with new business wins;
|
•
|
conditions in the economy as a whole and in the industries we serve;
|
•
|
fluctuations in components prices and component shortages or extended parts lead time caused by high demand, natural disaster or otherwise;
|
•
|
timing of new product development by our customers, which creates demand for our services, but which can also require us to incur start-up costs relating to new tooling and processes;
|
•
|
levels of demand in the end markets served by our customers;
|
•
|
timing of orders from customers and the accuracy of their forecasts;
|
•
|
inventory levels of customers, which if high relative to their normal sales volume, could cause them to reduce their orders to us;
|
•
|
timing of new program ramps in which expenditures are made in anticipation of increased sales or for which low product yields and design changes can significantly impact profitability;
|
•
|
customer product delivery requirements and shortages of components or labor;
|
•
|
increasing labor costs in the regions in which we operate;
|
•
|
mix of products ordered by and shipped to major customers, as high volume and low complexity manufacturing services typically have lower gross margins than more complex and lower volume services;
|
•
|
degree to which we are able to utilize our available manufacturing capacity;
|
•
|
customer insolvencies resulting in bad debt or inventory exposures that are in excess of our reserves;
|
•
|
our ability to efficiently move manufacturing activities to lower cost regions;
|
•
|
changes in our tax provision due to changes in our estimates of pre-tax income in the jurisdictions in which we operate, uncertain tax positions, and our ability to utilize our deferred tax assets; and
|
•
|
political and economic developments in countries in which we have operations which could restrict our operations or increase our costs.
|
•
|
the imposition of currency controls;
|
•
|
changes in trade and tax laws that may result in our customers being subjected to increased taxes, duties and tariffs and reduce their willingness to use our services in countries in which we are currently manufacturing their products;
|
•
|
compliance with U.S laws concerning trade, including the International Traffic in Arms Regulations (“ITAR”), the Export Administration Regulations (“EAR”), the Foreign Corrupt Practices Act (“FCPA”) and sanctions administered by the Office of Foreign Asset Controls (“OFAC”);
|
•
|
rising labor costs;
|
•
|
compliance with foreign labor laws, which generally provide for increased notice, severance and consultation requirements compared to U.S. laws;
|
•
|
labor unrest, including strikes;
|
•
|
difficulties in staffing due to immigration or travel restrictions imposed by national governments, including the U.S.;
|
•
|
security concerns;
|
•
|
political instability and/or regional military tension or hostilities;
|
•
|
inflexible employee contracts or labor laws in the event of business downturns;
|
•
|
coordinating communications among and managing our international operations;
|
•
|
fluctuations in currency exchange rates, which may either increase or decrease our operating costs and for which we have significant exposure;
|
•
|
changes in tax and trade laws that increase our local costs;
|
•
|
exposure to heightened corruption risks;
|
•
|
aggressive, selective or lax enforcement of laws and regulations by national governmental authorities;
|
•
|
adverse rulings in regards to tax audits; and
|
•
|
misappropriation of intellectual property.
|
Period (1)
|
|
TOTAL NUMBER OF SHARES PURCHASED
|
|
AVERAGE PRICE PAID PER SHARE
(2)
|
|
TOTAL NUMBER OF SHARES PURCHASED AS PART OF PUBLICLY ANNOUNCED PROGRAMS
|
|
MAXIMUM DOLLAR VALUE OF SHARES THAT MAY YET BE PURCHASED UNDER THE PROGRAMS
(2)
|
|
||||||
Month #1
|
|
|
|
|
|
|
|
|
|
||||||
October 1, 2017 through October 28, 2017
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
253,232,759
|
|
|
Month #2
|
|
|
|
|
|
|
|
|
|
||||||
October 29, 2017 through November 25, 2017
|
|
1,019,114
|
|
|
$
|
33.62
|
|
|
1,019,114
|
|
|
$
|
218,968,631
|
|
|
Month #3
|
|
|
|
|
|
|
|
|
|
||||||
November 26, 2017 through December 30, 2017
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
218,968,631
|
|
|
Total
|
|
1,019,114
|
|
|
|
|
1,019,114
|
|
|
|
|
(1)
|
All months shown are our fiscal months.
|
(2)
|
Amounts do not include commission payable on shares repurchased. The total average price paid per share is a weighted average based on the total number of shares repurchased during the period.
|
Exhibit Number
|
|
Description
|
|
|
|
31.1
|
|
|
|
|
|
31.2
|
|
|
|
|
|
32.1 (1)
|
|
|
|
|
|
32.2 (1)
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
(1)
|
This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.
|
|
|
SANMINA CORPORATION
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
By:
|
/s/ ROBERT K. EULAU
|
|
|
|
Robert K. Eulau
|
|
|
|
Chief Executive Officer (Principal Executive Officer)
|
|
|
|
|
Date:
|
February 2, 2018
|
|
|
|
|
|
|
|
|
By:
|
/s/ DAVID R. ANDERSON
|
|
|
|
David R. Anderson
|
|
|
|
Executive Vice President and
|
|
|
|
Chief Financial Officer (Principal Financial Officer)
|
|
|
|
|
Date:
|
February 2, 2018
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Suppliers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|